Lam Research Co. (NASDAQ:LRCX) Shares Bought by Tennessee Valley Asset Management Partners

Tennessee Valley Asset Management Partners boosted its position in shares of Lam Research Co. (NASDAQ:LRCX) by 900.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,344 shares of the semiconductor company’s stock after buying an additional 3,910 shares during the period. Tennessee Valley Asset Management Partners’ holdings in Lam Research were worth $314,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Quarry LP raised its stake in Lam Research by 175.0% in the 2nd quarter. Quarry LP now owns 88 shares of the semiconductor company’s stock valued at $94,000 after purchasing an additional 56 shares during the last quarter. NCP Inc. acquired a new stake in shares of Lam Research in the second quarter valued at about $213,000. Migdal Insurance & Financial Holdings Ltd. lifted its stake in shares of Lam Research by 2,400.0% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 200 shares of the semiconductor company’s stock worth $163,000 after buying an additional 192 shares in the last quarter. Advisory Alpha LLC acquired a new position in Lam Research during the second quarter worth about $256,000. Finally, Silver Lake Advisory LLC purchased a new stake in Lam Research during the 2nd quarter valued at about $261,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Stock Down 1.9 %

Lam Research stock opened at $79.68 on Monday. The firm has a market capitalization of $102.52 billion, a P/E ratio of 25.75, a P/E/G ratio of 1.53 and a beta of 1.45. The stock’s fifty day simple moving average is $75.43 and its 200-day simple moving average is $79.86. Lam Research Co. has a twelve month low of $68.87 and a twelve month high of $113.00. The company has a current ratio of 2.53, a quick ratio of 1.74 and a debt-to-equity ratio of 0.53.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Wednesday, December 11th were paid a $0.23 dividend. This represents a $0.92 annualized dividend and a dividend yield of 1.15%. The ex-dividend date was Wednesday, December 11th. Lam Research’s payout ratio is presently 29.74%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. BNP Paribas upgraded Lam Research to a “hold” rating in a report on Thursday, October 24th. KeyCorp raised Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 price objective on the stock in a research note on Friday, January 17th. Wolfe Research downgraded Lam Research from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, January 15th. Barclays lowered their price target on shares of Lam Research from $90.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Finally, Morgan Stanley raised their price objective on shares of Lam Research from $76.00 to $78.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 5th. Nine analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.77.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.